Forum Posts

broro75
Jun 10, 2022
In General Discussions
What code will you use for BOOP? BOOP stands for Bronchiolitis obliterans organizing pneumonia. It is a lung disease that causes inflammation in the small air tubes (bronchioles) and air sacs (alveoli). It can be caused by viruses, various drugs, and other medical conditions. In many cases, the underlying cause of BOOP is unknown. BOOP is characterized by granulation tissue in the bronchiolar lumen, alveolar ducts, and some alveoli, associated with a variable degree of interstitial and airspace infiltration by mononuclear cells and foamy macrophages. BOOP is differentiated from organizing pneumonia, which is defined by the presence of granulation tissue in the distal air spaces. But when associated with granulation tissue in the bronchiolar lumen, organizing pneumonia is qualified by the term bronchiolitis obliterans (BO). Hence the term "bronchiolitis obliterans organizing pneumonia" is used. Some medical practices submit the ICD-10 code J84.116 in claims when documentation describes BOOP perfectly. What do you think? Is this the correct code? Do you disagree? And why? Log in to share your response with us. <<...Perfect and well packaged...A must for Providers...>> People keep talking about it. Services and Products for Valid Documentation and Accurate MRA score How to Improve Risk Adjustment Documentation with a Self Study Web-Based Training Your eBook The best approach is to focus on the ACCURACY of the Patient's Health Status Risk Adjustment Documentation Challenge Are you a novice in the Risk Adjustment field? No worries! Just have access to our Framework for only $7
What code will you use for BOOP? content media
0
0
119
broro75
May 13, 2022
In General Discussions
The American Medical Association (AMA) is issuing the CPT code update to ensure electronic systems across the U.S. health care system are ready in advance for the potential FDA authorization. The AMA announced an editorial update to Current Procedural Terminology (CPT), including recently assigned provisional CPT codes for COVID-19 booster candidates from Pfizer and Sanofi-GlaxoSmithKline. Indeed, the CPT Editorial Panel has approved the addition of 35 Category I codes, including three Category I codes to report the Sanofi Pasteur booster vaccine code and its associated administration code, and the Pfizer booster code. The Sanofi-GSK booster candidate is proposed for use in persons age 18 and older who have completed a COVID-19 vaccine primary series. In contrast, the Pfizer booster candidate is suggested for use in children ages 5 to 11 who have completed a COVID-19 vaccine primary series. The Administration code for Pfizer booster candidate is : 0074A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose The product and administration codes for Sanofi-GSK booster candidate are: 91310: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use. 0104A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose. To know more about all the new vaccine-specific CPT codes, click HERE Who needs More Vitamin D Risk Adjustment documentation Challenge Product and services (Volume versus Quality) About chronic conditions Promote Valid Documentation Tips and tricks to know about Documenting for Medicare Advantage Patients Is it worth having a medical coder?
Newly assigned provisional CPT codes for COVID-19 booster candidates content media